Andy Garland joins Omega 365 as Life Sciences consultant
In mid-April, Andy Garland began a three- to six-month consultancy assignment with Omega 365. Based in Denmark, Andy brings extensive executive experience from the Life Sciences sector, having previously served as Vice President at Novo Nordisk, where he played a key role in securing the Omega 365 contract and supporting its implementation.
Photo: Andy Garland will focus particularly on the pharmaceutical and biotechnology industries.
Andy’s role will focus on strengthening Omega 365’s collaboration with selected Life Sciences companies, particularly within the pharmaceutical and biotechnology industries. He will support how Omega 365’s project and asset management solutions can create value for clients and contribute to ongoing projects globally.
“We look forward to drawing on Andy’s network and expertise to further support our work within Life Sciences,” says Ståle Håheim, Enterprise Sales Executive EMEA.
While Life Sciences will be his main focus, Andy may also contribute to opportunities in other relevant industries where valuable projects have been identified and agreed upon.
“Having seen the challenges companies face in delivering large, complex capital projects, I understand the importance of well-structured and integrated data to provide insight and visibility. I look forward to contributing to Omega 365’s continued growth and to building strong relationships in the industry,” says Andy Garland.
Welcome, Andy!
.jpg?scale=thumbnail)
